Review: Detection of Cancer Biomarkers from a Clinical Perspective
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311745 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xeniya Terzapulo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, School of Sciences and Humanities, Nazarbayev University, Kabanbay Batyr Ave. 53, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nazarbayev University.
Abstract (Originalsprache)
Cancer is the disease found to be the reason for the largest portion of deaths in the world annually and these mortality values are expected to increase in the future. Early detection of cancer biomarkers may help save millions of lives, particularly by implementing non-invasive and economical detection methods. In this review, we tabulated and quantitatively compared the data collected in 173 rows from 124 publications, which describe the clinical application of various methods in detection of cancer biomarkers. Those methods include mass spectrometry (MS), immunoassays (IAs), enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), surface-enhanced Raman spectroscopy (SERS), and Fourier-transform infrared spectroscopy (FTIR). We found that direct methods may have an advantage over indirect methods. Direct SERS reported in clinical applications can also achieve a higher area under the curve, higher sensitivity, and specificity than those parameters for ELISA, PCR, MS, and FTIR applications. Based on the average area under the curve (AUC) values reported in the last 6–7 years for each method, the performance of the analytical methods for the clinical cancer detection increases from IAs (0.76), ELISA (0.83), MS (0.87), and PCR (0.89) to FTIR (0.95) and SERS (0.97).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Department, School of Sciences and Humanities, Nazarbayev University, Kabanbay Batyr Ave. 53, Astana 010000, Kazakhstan.
- Biology Department, School of Sciences and Humanities, Nazarbayev University, Kabanbay Batyr Ave. 53, Astana 010000, Kazakhstan.
- Department of Medicine, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan.
ORCID-Profile: Xeniya Terzapulo, Yegor Shevchenko, Abduzhappar Gaipov, Rostislav Bukasov
Förderung
- Nazarbayev University
Zitieren
APA
Terzapulo, X., Dyussupova, A., Ilyas, A., Boranova, A., Shevchenko, Y., Mergenbayeva, S., Kassenova, A., Filchakova, O., Gaipov, A., & Bukasov, R. (2025). Review: Detection of Cancer Biomarkers from a Clinical Perspective. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311745
Vancouver
Terzapulo X, Dyussupova A, Ilyas A, Boranova A, Shevchenko Y, Mergenbayeva S, et al. Review: Detection of Cancer Biomarkers from a Clinical Perspective. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311745
BibTeX
@article{Terzapulo2025,
author = {Terzapulo, Xeniya and Dyussupova, Aigerim and Ilyas, Aisha and Boranova, Aigerim and Shevchenko, Yegor and Mergenbayeva, Saule and Kassenova, Aiym and Filchakova, Olena and Gaipov, Abduzhappar and Bukasov, Rostislav},
title = {Review: Detection of Cancer Biomarkers from a Clinical Perspective},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311745}
}
EUVIMED